Eli Lilly concludes acquisition of DICE Therapeutics Ruchika Sharma12 Aug 2023 2:30 PM ISTIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of DICE Therapeutics, Inc.. The acquisition...
Eli Lilly sued by Nektar Therapeutics over autoimmune disease treatment Ruchika Sharma8 Aug 2023 1:30 PM ISTUS: Nektar Therapeutics has sued Eli Lilly, accusing the U.S. drugmaker of undermining the prospects for a drug the companies were developing...
Eli Lilly- Boehringer Ingelheim Jardiance gets European Commission nod to treat adults with CKD Ruchika Sharma26 July 2023 4:30 PM ISTIngelheim: The European Commission (EC) has approved Jardiance (empagliflozin) for the treatment of adults with chronic kidney disease (CKD),...
Eli Lilly presents results from Phase 3 trial of Donanemab at Alzheimer's Association Conference Ruchika Sharma19 July 2023 12:39 PM ISTIndianapolis: Eli Lilly and Company has presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly...
Eli Lilly to acquire Versanis for USD 1.925 billion Ruchika Sharma15 July 2023 1:00 PM ISTIndianapolis: Eli Lilly and Company and Versanis Bio have announced a definitive agreement for Lilly to acquire Versanis, a private...
Eli Lilly to buy Sigilon Therapeutics Ruchika Sharma2 July 2023 1:00 PM ISTIndianapolis: Eli Lilly and Companyand Sigilon Therapeutics, Inc. have announced a definitive agreement for Lilly to acquire Sigilon, a...
Eli Lilly to acquire DICE Therapeutics Ruchika Sharma25 Jun 2023 10:00 AM ISTLilly will commence a tender offer to acquire all outstanding shares of DICE for a purchase price of USD 48 per share in cash payable at closing.
Eli Lilly-Boehringer Ingelheim bags USFDA nod for Type 2 diabetes drugs Jardiance, Synjardy for children Ruchika Sharma21 Jun 2023 4:30 PM ISTUnited States: The U.S. Food and Drug Administration (FDA) on Tuesday approved Eli Lilly and partner Boehringer Ingelheim's drugs Jardiance and...
Eli Lilly raises annual profit forecast on strength of diabetes drug Ruchika Sharma30 April 2023 2:30 PM ISTBengaluru: Eli Lilly and Co on Thursday raised its annual revenue and profit forecasts after topping first-quarter sales estimates on demand for its...
Eli Lilly to divest hypoglycemia treatment BAQSIMI to Amphastar Ruchika Sharma24 April 2023 5:08 PM ISTPursuant to the terms of the agreement, Amphastar will pay Lilly USD 500 million in cash at closing and an additional USD 125 million in cash upon the...
Eli Lilly to invest additional USD 1.6 billion in 2 new plants Ruchika Sharma18 April 2023 1:30 PM ISTIndianapolis: Eli Lilly and Company has announced that it will invest an additional $1.6 billion and add another 200 new jobs at its two new...
Eli Lilly bowel disease drug Mirikizumab rejected by USFDA Ruchika Sharma14 April 2023 3:00 PM ISTThe health regulator cited issues related to the proposed manufacturing of the drug mirikizumab.
